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Abstract
Eosinophilic esophagitis (EoE) is a chronic immune-mediated condition believed to have an
allergic component, but the timing of the initial allergen triggers that cause the disease is poorly
understood. While the clinical presentation of EoE is often of longstanding symptoms, in animal
models, acute exposure to an allergen challenge successfully produces EoE. In this report, we
present three cases of individuals who developed esophageal eosinophilia and EoE shortly after a
clearly identified exposure to aeroallergens. These cases highlight the allergic etiology of EoE,
and provide a link from humans to the previously described experimental mechanisms.
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Introduction
Eosinophilic esophagitis (EoE) is a recently recognized disease defined by symptoms of
esophageal dysfunction and an eosinophilic infiltrate in the esophageal mucosa.[1] The
underlying pathogenesis is thought to involve a Th2 immune response to allergens.[2, 3] It
has been hypothesized that food and aeroallergens play a role in the etiology of EoE, and in
humans elimination or elemental diets lead to symptom improvement,[4–7] there is seasonal
variation in diagnosis,[8–10] and esophageal eosinophilia varies based on climate zone.[11]
In murine models, EoE has been produced by intra-nasal exposure to allergens such as
Aspergillus fumigatus or ovalbumin after both respiratory and epicutaneous sensitization.
[12–14] While this mechanism is presumed to operate in humans, to date there are no direct
data to support this hypothesis, and on a clinical basis, the ability to determine a clear
allergen exposure responsible for the onset of EoE is rare. Here, we present three instances
where patients developed esophageal eosinophilia and EoE after a large and clearly
identifiable aeroallergen exposure.
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The patient is a 22 year-old man with a history of anxiety, depression, obesity, and seasonal
allergies who presented with dysphagia and heartburn. Three months prior to presentation,
which was during the mid-spring, he was mowing his lawn. The mower jammed, backfired,
and expelled a large amount of grass clippings into his face. He believed he may have
swallowed some of the debris. Beginning within days of this exposure, he began having
progressive solid-food dysphagia with a sense of food hanging in his upper esophagus. He
had no difficulty with liquids. He also had associated substernal burning, a hoarse voice,
globus sensation, and poor appetite. He had a subsequent 50 lb weight loss (though he
remained obese). His initial esophagogastroduodenoscopy (EGD) 2 months after his
exposure showed a ringed esophagus with longitudinal furrows (Figure 1A), and mid-
esophageal biopsies revealed 45 eosinophils per high powered field (eos/hpf; hpf area =
0.24mm2). He was then started on omeprazole 20 mg twice daily for 8 weeks with an
improvement in his symptoms. Follow up EGD showed persistent rings and only subtle
furrows (Figure 1B), and biopsies demonstrated 4 eos/hpf in the distal esophagus and 2 eos/
hpf in the proximal esophagus. This clinical picture was felt to be consistent with proton-
pump inhibitor-responsive esophageal eosinophilia (PPI-REE), and omeprazole was
decreased to once daily dosing. He did well for three months of follow-up, was monitored
expectantly thereafter, and has not sought further care for recurrent symptoms.
Case 2
The patient is a 20 year-old man with a history of depression and no known atopy who
presented with dysphagia and chest pain. Prior to symptom onset, he was tasked at work to
clean a small enclosed room that had become moldy. During the cleaning process, he
believed that he inhaled and swallowed mold and dust. Subsequently, he began having a
sore throat and increased difficulty swallowing. Within 10 days of his exposure he presented
to an outside emergency department with a frank food impaction. EGD there revealed a
feline esophagus with furrows and plaques, and random esophageal biopsies showed 30 eos/
hpf. His symptoms did not resolve after treatment with swallowed topical fluticasone and
budesonide, oral prednisone, and intravenous methylprednisolone. On presentation to our
facility, he had ongoing dysphagia to solids with food sticking in the upper esophagus that
would pass with large amounts of fluid intake, chest discomfort, and a 25–30 lb weight loss
which he attributed primarily to decreased oral intake. A repeat EGD about 6 months after
his exposure and after 8 weeks of treatment with esomeprazole 40 mg twice daily showed
esophageal rings, linear furrows, and decreased vascularity (Figure 2). Biopsies showed 40
eos/hpf in both the distal and proximal esophagus consistent with EoE. The plan was to
institute high-dose topical steroid therapy but the patient moved out of state and did not
follow-up. Allergy testing was not performed on this patient, so sensitization remains
unknown.
Case 3
This patient is a 39 year-old man with a history of asthma who presented with dysphagia
which developed after renovating a home he purchased as a foreclosure property. He noted
exposure to saw dust, mold, and dust during this work, particularly when he was removing
rotted drywall and wood. About six months after his exposure, he began having solid food
dysphagia and a sense of transient impaction of food. He was initially able to control
symptoms by shifting to a soft food diet with nutritional supplements but could not meet his
caloric requirements and lost 20 lbs. Allergy testing with skin prick showed no food
allergies but did reveal IgE-sensitization to mites, house dust, grasses, and cats. Upper
endoscopy one year after his exposure showed esophageal rings, furrows, and decreased
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vascularity (Figure 3), with distal esophageal scarring associated with pseudodiverticula and
erythema. Pathology revealed >60 eos/hpf distally and 25 eos/hpf proximally with
eosinophilic microabscesses. Lansoprazole 30 mg twice daily was started, and on repeat
EGD there were persistent esophageal rings, scarring, and pseudodiverticuli, but the
furrowing and erythema had resolved. Biopsies showed persistent esophageal eosinophilia
with 40 eos/hpf in both the distal and proximal esophagus, confirming the diagnosis of EoE.
He declined repeat allergy evaluation, and started an oral viscous budesonide slurry (1 mg
twice daily mixed with 5g sucralose). Symptoms persisted and repeat EGD showed
continuing endoscopic changes with ongoing esophageal eosinophilia on biopsy.
Discussion
Eosinophilic esophagitis is an immune-mediated disorder that has rapidly become an
important cause of upper GI morbidity.[1] The evidence base for EoE as immune-mediated
comes from a wide range of publications. First, a number of studies have noted a strong
association between EoE and other atopic disorders such as asthma, allergic rhinitis and
sinusitis, atopic dermatitis, and food allergies.[9, 15–19] Second, dietary therapy of EoE
with elimination or elemental diets leads to symptom improvement and resolution of
esophageal eosinophilia.[4–7] Third, seasonal variation in the diagnosis of EoE has been
reported at a number of centers,[8–10] and the prevalence of esophageal eosinophilia varies
based on climate zone in the United States.[11] Fourth, there has been a report of a few
cases of EoE possibly induced by oral immunotherapy (OIT), i.e., as a result of allergen
exposure.[20] Finally, a wealth of basic science research has shown that EoE is a Th2
mediated process where proinflammatory cytokines such as IL-4, IL-5, and IL-13 and the
chemokine eotaxin-3 promote eosinophilic recruitment and infiltration of the esophageal
mucosa, and that this process is reversible after eliminating offending allergens.[1–3, 21, 22]
While the allergic basis of EoE is becoming more well characterized, it is difficult to
identify the initial allergen insult. Even a food elimination and reintroduction protocol, while
effective for many patients in identifying certain triggers,[7, 23] does not necessarily
pinpoint the inciting event that causes EoE.
In this report, we present three cases where development of symptoms of esophageal
dysfunction, esophageal eosinophilia, and EoE occurred shortly after a large and identifiable
allergen exposure. In the first, the patient had known seasonal allergies and developed PPI-
REE after inhalation and possible swallowing of grass clippings. In the second and third,
while neither patient had known allergies before participating in cleaning and renovations
that led to mold and dust exposures and development of frank EoE, allergic sensitization
was demonstrated after the fact for the third patient. Both of these cases were also refractory
to initial attempts at topical steroid therapy. To our knowledge, these are the first reports of
esophageal eosinophilia and EoE that developed after large allergen exposures in humans.
Despite only three case descriptions, we feel there are several important issues raised by our
observations.
First, in these cases, the human development of EoE appears to mimic the mechanism seen
in animal models. In murine models first established by Mishra and colleagues and
subsequently used to understand the pathogenesis of EoE,[12, 14, 24, 25] the core
mechanism for producing EoE is allergen exposure. Specifically, mice with respiratory, oral,
or epicutaneous sensitization that are rechallenged with intra-nasal exposure to allergens
develop esophageal eosinophilic infiltrates which mimics EoE.[12, 14] Longer follow-up of
experimental EoE models also show esophageal remodeling and strictures.[26] For our
cases, it is interesting that patients 1 and 3 either had a history of seasonal allergies or
eventually tested positive for environmental allergens, potentially indicating past
sensitization. All three had a large antigen challenge, likely by the respiratory and possibly
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by a swallowed route. For cases 2 and 3, they were exposed to mold, which echoes the
Aspergillus challenge in mice.[13] While it has been long supposed that the murine model
recapitulated the clinical scenario, until now human cases have been lacking to support that
exact mechanism. Total serum IgE levels and peripheral eosinophil counts were not
available for these patients, however.
Second, these cases suggest the importance of aeroallergen exposure in EoE. This is
consistent with findings of seasonality and geographic distribution of EoE cases.[3, 8–11,
27–29] However, previous studies have explored associations between atopic disease and
EoE, or month of diagnosis of EoE, but none show the initial allergen exposure that caused
EoE.
Third, it is interesting to note the two patients with EoE in this report were refractory to
initial treatments with topical steroids. This is consistent with some data showing that
patients with atopic disease or ongoing allergen exposure may be more difficult to treat with
topical corticosteroids.[30]
Finally, case 1 may be the first link of the PPI-REE phenotype to an allergic mechanism.
PPI-REE has been only recently described,[31–34] and there are few details available to
characterize these patients. It is not currently known if PPI-REE is a manifestation of
GERD, a sub-type of EoE, or a different disease process,[1] but this case raises the question
of whether PPI-REE might be immune-mediated.
These observations must be tempered by that acknowledgement that this is a case series of
three patients. Nevertheless, it is interesting that these patients developed esophageal
eosinophilia and EoE via a mechanism that is similar to the murine model for EoE. The
cases also generate hypotheses that can be investigated in larger studies, and provide
examples that, in some cases, the initial instigating trigger for EoE can be identified.
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Endoscopic views of the esophagus in case 1 prior to (A) and after (B) PPI therapy. Before
PPI, there are prominent fixed esophageal rings and decreased vascularity. After PPI, the
rings are nearly resolved and vascularity is normal.
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Endoscopic view of case 2 with esophageal rings, linear furrows, and decreased vascularity.
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Endoscopic view of case 3 with esophageal rings, linear furrows, and decreased vascularity.
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